Steven Friedman

Executive Vice President, Biology and Preclinical Development

Incyte

Profile privacy

Get Free Access to Steven’s Contact Info

Connect with Steven Friedman, Now

According to Datanyze information, these are Steven Friedman's contact details. Reveal the hidden information below for FREE!

Phone (HQ)

(302) 498-6700

Phone (HQ)

❅❅❅❅❅@incyte.com

Office Address (HQ)

1801 Augustine Cut Off, Wilmington, Delaware, 19803, United States

Office Address (HQ)

Reveal for Free

Work Biography for Steven Friedman, Incyte

Steven Friedman works as a Executive Vice President, Biology and Preclinical Development at Incyte, which is a Business Services company with an estimated 2,524 employees; and founded in 2002., their management level is VP-Level. Steven graduated from American Board of Internal Medicine and is currently based in Wilmington, United States.

Flattery will get you everywhere, offer Steven a compliment to ❄️

Education

B. A.

Princeton University

M. D.

Cornell University Medical College

American Board of Internal Medicine

Steven's Workplace

Incyte

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chr...Read More

1801 Augustine Cut Off, Wilmington, Delaware, 19803, United States

2,524

$3.9 B

Business Services, Research & Development

Get Full Profile Access

Ice Breakers

Imagine you could know all about Incyte - Steven Friedman’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers

Steven’s company in the news

Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer

September 14, 2024

Incyte CEO views PD-1 drug Zynyz as oncology pipeline aide - Fierce Pharma

September 14, 2024

Incyte’s Retifanlimab (Zynyz®) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium

September 14, 2024

Insights to Break the Ice

In your first interaction

Steven’s CEO is Herve Hoppenot

Steven is located in United States

Work Colleague

See Steven Friedman's coworkers out of Incyte's 2,524 employees

Name & Title	Contact Info
Herve Hoppenot Chairman, President & Chief Executive Officer	❅❅❅❅❅@incyte.com +1 302 ❅❅❅ ❅❅❅❅	Reveal for Free
Pablo Cagnoni President & Head of Research & Development	❅❅❅❅❅@incyte.com +1 617 ❅❅❅ ❅❅❅❅	Reveal for Free
Steven Stein Executive Vice President, Chief Medical Officer	❅❅❅❅❅@incyte.com	Reveal for Free
Paula Swain Executive VP, Human Resources	❅❅❅❅❅@incyte.com +1 302 ❅❅❅ ❅❅❅❅	Reveal for Free
Sylvian Osango Manufacturing Finance Controller		Reveal for Free
Yao Wenqing Executive Vice President	❅❅❅❅❅@incyte.com	Reveal for Free
Thomas Tray Vice President, Chief Accounting Officer	❅❅❅❅❅@incyte.com +1 302 ❅❅❅ ❅❅❅❅	Reveal for Free